Materials · Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics

ECL Ecolab SEC Filings & Insider Trading Activity 2026

company
CIK 31462130 filings
S&P 500

ECL at a glance

Ecolab (ECL, SEC CIK 31462) filed its latest 10-K annual report on February 23, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on July 28, 2026 and Form 4 insider filings as recently as October 2, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), Ecolab (ECL) reported revenue of $16.1 billion (up 2.2% from FY2024) and net income of $2.1 billion. Diluted EPS was $7.28.
  • As of June 30, 2026, 52 institutional investment managers tracked by SignalX reported holding Ecolab (ECL) shares worth $30.5 billion in 13F-HR filings.
  • In the last 90 days, ECL insiders reported 2 open-market purchases ($1.0M) and 3 open-market sales ($7.2M) on Form 4, a net sale of $6.2M.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$16.1B
+2.2% vs prior year
Insiders · 90 days
2 buys · 3 sells
Net −$6.2M
13F holders
52 funds
$30.5B · −4 vs prior quarter
Latest 8-K
Jul 28, 2026
Item 2.02

AI 10-K Annual Report Analysis

Latest 10-K, fiscal year ended Dec 31, 2025

Full analysis →

Risk Factors

  • ~47% of net sales from outside U.S. with exposure to tariffs, retaliatory trade measures, and currency risk in 170+ countries
  • $8.2B total debt outstanding, ~$1.5B floating rate; 1pp rate increase adds ~$15M annual interest expense
  • U.S. Gulf Coast concentration risk: key raw material source and customer base for Light & Heavy segment, vulnerable to hurricanes and severe weather
  • OECD Pillar Two 15% global minimum tax now effective in multiple jurisdictions; OBBBA interaction creates complex compliance and double-taxation risk
  • AI and ERP upgrade execution risk: ongoing multi-phase ERP rollout plus "One Ecolab" restructuring; failure could cause business disruption and financial losses

Management Discussion & Analysis

  • Revenue $16.1B, up 2% YoY ($339.8M increase); organic sales +3%, driven by pricing and volume across all segments
  • Reported operating margin 17.0% vs 17.8% in 2024; adjusted operating margin 18.0% vs 16.6%, boosted by value pricing and productivity
  • Best segment: Global Institutional & Specialty, organic operating margin 22.8% vs 19.9%; worst: Global Life Sciences, smallest at $706M sales despite margin recovery to 17.1% vs 13.7%
  • Operating cash flow $3.0B vs $2.8B; capex $1.0B; share buybacks $784M; dividends paid $754M; Ovivo Electronics acquired for $1.6B cash
  • One Ecolab restructuring expanded Feb 2026 to $334M total cost targeting $325M annualized savings by 2027; FX exposure and geopolitical risk (Russia/Ukraine ~1% of sales) cited as key risks

Business Overview

  • Global leader in water, hygiene and infection prevention; $16B annual sales, 48,000 associates, 170+ countries, 40 industries
  • Four reportable segments this filing: Global Water, Global Institutional & Specialty, Global Pest Elimination, Global Life Sciences; Life Sciences explicitly elevated as standalone segment
  • Warewashing products grew to 13% of consolidated net sales in 2025, up from 12% in 2024 and 2023: only product line disclosed at 10%+ threshold
  • Capital expenditures for environmental, health and safety projects held steady at ~$62M in 2025 (vs $46M in 2023), with $59M budgeted for 2026
  • Workforce of ~25,000 in sales/service roles plus ~3,000 R&D/digital experts; 43% North America, notable 8% India/Middle East/Africa concentration disclosed

AI summary of the ECL 10-K filed . Generated from the filing text; verify against the original.View on SEC EDGARHow to read a 10-K

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Jun 30, 2026

Management Discussion & Analysis

  • Revenue $4,415.4M, up 10% YoY from $4,025.2M; organic sales $4,282.1M, up 5%
  • Reported operating margin 17.2% vs 17.6% YoY; organic margin 18.8% vs 18.4%
  • Best performer Global Life Sciences, sales $221.0M, up 15%; worst Heavy Water, organic sales down 1%
  • Global Life Sciences operating income $58.5M, up 46% from $40.2M
  • One Ecolab delivered $180M cumulative savings; planned annualized savings $325M by 2027

Risk Factors

  • Risk Factors section not provided; no new or changed risks identifiable
  • No regulatory, legal, compliance, operational, competitive, market, or financial risks disclosed in supplied text
  • New term credit agreement dated April 10, 2026, but terms and related risk impacts not provided
  • Senior notes issued with maturities in 2029, 2031, 2033, and 2036; principal amounts not provided

AI summary of the ECL 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Jul 28, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q2 sales $4.4B, up 10%, with organic growth accelerating to 5%; pricing reached 4% despite Middle East disruptions
  • Adjusted diluted EPS $2.09, up 11%, while reported EPS rose 3% to $1.90; productivity offset commodity inflation

Item 2.02: Results of Operations and Financial Condition

  • Q2 2026 earnings materials filed July 28, 2026
  • News release and supplemental second-quarter data available as Exhibits 99.1 and 99.2
Filed May 29, 2026Full analysis →

Item 8.01: Other Events

  • $5.0B debt offering completed to fund CoolIT Systems acquisition and general corporate purposes
  • Notes span 2029–2036 maturities with fixed coupons of 4.600%–5.350%, increasing long-term interest obligations
Filed May 11, 2026Full analysis →

Item 5.02: Departure/Appointment of Directors or Principal Officers

  • Bryce L. Mewhorter elected Senior Vice President and Corporate Controller, becoming principal accounting officer after Ecolab’s Q2 2026 Form 10-Q filing
  • Jennifer J. Bradway continues as controller through the transition before assuming another Company role

Item 5.07: Submission of Matters to a Vote of Security Holders

  • Annual meeting quorum: 254.3M shares represented, or majority of 282.4M outstanding shares
  • All 13 director nominees elected for one-year terms, including John J. Zillmer with 188.7M votes for and 50.0M against

AI summaries of ECL 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for ECL

Don't miss the next ECL filing

  • Alerts as it files. A push when ECL files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut ECL, by share count.
  • Ask anything. An AI agent that reads every ECL filing and answers with sources.

ECL alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Ballard Shari LASep 30, 2026$276.36
LARSON MICHAELASep 30, 2026-
Ballard Shari LASep 30, 2026-
Green Eric MarkASep 30, 2026$276.36
Green Eric MarkASep 30, 2026-
Althoff JudsonASep 30, 2026-
McKibben Tracy BASep 30, 2026-
MacLennan DavidASep 30, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$15.7B$16.1B
Operating Income$2.0B$2.8B$2.7B
Net Income$1.4B$2.1B$2.1B
Op. Margin-17.8%17.0%
Net Margin-13.4%12.9%
Balance Sheet
Total Assets-$22.4B$24.7B
Equity-$8.8B$9.8B
ROE-24.1%21.2%
Per Share
EPS-$7.37$7.28
Cash Flow
Operating CF$2.4B$2.8B$3.0B
CapEx$774.8M$994.5M$1.0B

Source: XBRL data in Ecolab (ECL)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q2 2026

Aggregate ECL share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
ECL shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q2 202652$30.48B
Q1 202656$28.21B
Q4 202553$27.68B
Q3 202555$30.69B
Q2 202553$27.11B
Q1 202549$19.36B
Q4 202445$14.69B
Q3 202442$8.97B
Position changes: Q1 2026 → Q2 2026
Top Buyers
Top Sellers
New Positions
None this quarter.

Source: 13F-HR filings on SEC EDGAR (aggregated from 405 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

ECL filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Oct 2, 2026--
4Sep 14, 2026--
4Aug 20, 2026--
4Aug 11, 2026--
10-QAug 6, 2026Analysis
4Aug 5, 2026--
4Jul 31, 2026--
8-KJul 28, 2026Analysis-
SC 13GJul 16, 2026-
4Jul 2, 2026--
4Jul 2, 2026--
4Jul 2, 2026--
4Jul 2, 2026--
4Jul 2, 2026--

Related Materials companies

All Materials →

ECL SEC filings: frequently asked questions

Are ECL insiders buying or selling?

In the last 90 days, Ecolab (ECL) officers, directors and 10% owners reported 2 open-market purchases worth $1.0 million by 1 insider and 3 open-market sales worth $7.2 million by 3 insiders on Form 4, a net sale of $6.2 million. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold ECL stock?

As of June 30, 2026, the largest Ecolab (ECL) holders among the 13F filers tracked by SignalX were BlackRock ($6.4 billion), Vanguard Capital Management LLC ($4.6 billion), JPMorgan Chase & Co ($4.1 billion), State Street Corp ($3.3 billion), Morgan Stanley ($2.2 billion). 13F-HR reports are filed up to 45 days after each quarter ends.

What was ECL's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), Ecolab (ECL) reported revenue of $16.1 billion (up 2.2% from FY2024) and net income of $2.1 billion. Diluted EPS was $7.28. The figures come from the XBRL data in the 10-K.

What are the main risks in ECL's latest 10-K?

In the 10-K filed February 23, 2026, Ecolab (ECL) flagged: ~47% of net sales from outside U.S. with exposure to tariffs, retaliatory trade measures, and currency risk in 170+ countries. $8.2B total debt outstanding, ~$1.5B floating rate; 1pp rate increase adds ~$15M annual interest expense. (AI summary of the Risk Factors section.)

What did ECL report in its latest 8-K?

Ecolab (ECL) filed an 8-K on July 28, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q2 sales $4.4B, up 10%, with organic growth accelerating to 5%; pricing reached 4% despite Middle East disruptions.

What are the latest ECL SEC filings?

Ecolab (ECL) filed its latest 10-K annual report on February 23, 2026, a 10-Q quarterly report on August 6, 2026, an 8-K current report on July 28, 2026 and a Form 4 insider filing on October 2, 2026.

What is ECL's SEC CIK number?

Ecolab (ECL)'s SEC Central Index Key (CIK) is 31462. EDGAR lists every ECL filing under that number.

Ask anything about ECL

The research agent reads ECL's filings, financials, insider trades and 13F holders, then answers with sources.